| 2025 Financial Year |
| 31 Oct 2024 |
Bubs Q1 FY25 Quarterly Activity and Cashflow Statement
|
View PDF
|
| 14 Oct 2024 |
Appendix 4G
|
View PDF
|
| 14 Oct 2024 |
Corporate Governance Statement
|
View PDF
|
| 14 Oct 2024 |
Annual Report to shareholders
|
View PDF
|
| 28 Aug 2024 |
Bubs FY24 Results Presentation
|
View PDF
|
| 28 Aug 2024 |
Bubs FY24 Results
|
View PDF
|
| 28 Aug 2024 |
Bubs – FY24 Appendix 4E Preliminary Final Report
|
View PDF
|
| 27 Aug 2024 |
FY24 Results Presentation Webinar Notification
|
View PDF
|
| 29 Jul 2024 |
Bubs Q4 FY24 Quarterly Activity and Cashflow Statement
|
View PDF
|
| 2024 Financial Year |
| 26 Jun 2024 |
Chief Financial Officer Robin Johnston to Retire
|
View PDF
|
| 13 Jun 2024 |
Trading Update
|
View PDF
|
| 30 Apr 2024 |
Bubs Q3 FY24 Quarterly Activity and Cashflow Statement
|
View PDF
|
| 27 Mar 2024 |
ASX Conference – Investor Presentation
|
View PDF
|
| 25 Mar 2024 |
BUBs Investor Update – Pathway to Profitability
|
View PDF
|
| 18 Mar 2024 |
Bubs US Growth Continues at Pace
|
View PDF
|
| 14 Mar 2024 |
Investor Webinar Presentation
|
View PDF
|
| 26 Feb 2024 |
Bubs Australia – Half Year Results Presentation
|
View PDF
|
| 26 Feb 2024 |
Bubs Australia – Half Year Results Commentary
|
View PDF
|
| 26 Feb 2024 |
Bubs Australia – Half Year Report and Appendix 4D
|
View PDF
|
| 23 Feb 2024 |
H1 FY24 Results Presentation – Details of Briefing
|
View PDF
|
| 31 Jan 2024 |
Bubs Q2 FY24 Quarterly Activity and Cashflow Statement
|
View PDF
|
| 21 Dec 2023 |
Bubs Results of Share Purchase Plan
|
View PDF
|
| 1 Dec 2023 |
Bubs Share Purchase Plan Offer Opens and SPP Booklet
|
View PDF
|
| 30 Nov 2023 |
Cleansing Notice
|
View PDF
|
| 24 Nov 2023 |
Proposed issue of securities – BUB
|
View PDF
|
| 24 Nov 2023 |
Capital Raising Investor Presentation
|
View PDF
|
| 24 Nov 2023 |
Completion of $14M Placement and Launches SPP
|
View PDF
|
| 22 Nov 2023 |
Trading Halt
|
View PDF
|
| 14 Nov 2023 |
2023 Annual General Meeting – CEO Address
|
View PDF
|
| 14 Nov 2023 |
Results of 2023 Annual General Meeting
|
View PDF
|
| 14 Nov 2023 |
2023 Annual General Meeting – CEO Presentation
|
View PDF
|
| 14 Nov 2023 |
2023 Annual General Meeting – Chair Address
|
View PDF
|
| 7 Nov 2023 |
Bubs Governance Changes
|
View PDF
|
| 24 Oct 2023 |
Q1 FY24 Quarterly Activities Report & Appendix 4C Cashflow Statement
|
View PDF
|
| 18 Oct 2023 |
Bubs Annual General Meeting – Notice of Access
|
View PDF
|
| 18 Oct 2023 |
Notice of Annual General Meeting/Proxy Form
|
View PDF
|
| 18 Oct 2023 |
Application for quotation of securities – BUB
|
View PDF
|
| 26 Sep 2023 |
Bubs – Date of AGM Notification
|
View PDF
|
| 12 Sep 2023 |
FY23 Results Presentation Webinar
|
View PDF
|
| 7 Sep 2023 |
FY23 Annual Report to Shareholders
|
View PDF
|
| 7 Sep 2023 |
US-Based Infant Formula Clinical Trial
|
View PDF
|
| 7 Sep 2023 |
Bubs Corporate Governance Statement
|
View PDF
|
| 7 Sep 2023 |
Appendix 4G.
|
View PDF
|
| 7 Sep 2023 |
FY23 Results Presentation
|
View PDF
|
| 31 Aug 2023 |
Bubs FY23 Results
|
View PDF
|
| 31 Aug 2023 |
Bubs 2023 Appendix 4E – Preliminary Final Report
|
View PDF
|
| 29 Aug 2023 |
CEO Appointment
|
View PDF
|
| 31 Jul 2023 |
Q4 FY23 Quarterly Activities Report and Appendix 4C Cashflow Statement
|
View PDF
|
| 27 Jul 2023 |
Shareholders Vote of Confidence for Board – Board retained as all resolutions voted down
|
View PDF
|
| 27 Jul 2023 |
Results of Extraordinary General Meeting
|
View PDF
|
| 27 Jul 2023 |
Bubs Extraordinary General Meeting
|
View PDF
|
| 12 Jul 2023 |
Alpha Group Legal Dispute Update
|
View PDF
|
| 6 Jul 2023 |
Strategic Review Update Presentation
|
View PDF
|
| 6 Jul 2023 |
Strategic Review Update Presentation (Mandarin)
|
View PDF
|
| 6 Jul 2023 |
Strategic Review Outcome
|
View PDF
|
| 4 Jul 2023 |
Strategic Review Details of Webcast
|
View PDF
|
| 3 Jul 2023 |
Alpha Group Legal Dispute
|
View PDF
|